COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 3rd May 2020. As a result, our offices will now be closed till 3rd May 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details.,, Mob. 8826373757, 8826859373, 9910947804

Print ISSN:-2394-2789

Online ISSN:-2394-2797


Current Issue

Year 2020

Volume: 7 , Issue: 1

Article Access statistics

Viewed: 242

Emailed: 0

PDF Downloaded: 114

International Journal of Pharmaceutical Chemistry and Analysis

Design and development of transdermal drug delivery systems of metoprolol succinate

Full Text PDF Share on Facebook Share on Twitter

Author Details : D MK. Chakradhar, A Sunitha, B Sofia, Grandhi Srikar*

Volume : 6, Issue : 3, Year : 2019

Article Page : 76-84

Suggest article by email


Introduction: Most of the drugs taken orally are found to be not as effective as desired. To overcome such problems transdermal drug delivery system has been developed. Transdermal drug delivery systems (TDDS) are dosage forms which involve in the drug transport to viable epidermal and or dermal tissues of the skin for local therapeutic effect while a very major fraction of drug is transported into the systemic blood circulation. Several important advantages of transdermal drug delivery are limitation of hepatic first pass metabolism, enhancement of therapeutic efficacy and maintenance of steady plasma level of the drug.
Materials and Methods: The current research work includes the development of Metoprolol succinate transdermal patches and their evaluation. The transdermal patches were formulated by solvent casting method varying the concentrations of Eudragit NE 30D (%v/w) and DMSO (%w/w of dry polymer).
Results: Among the nine formulations of the transdermal patches F3 formulation was considered as the optimized formulation considering its tensile strength, percentage elongation, percentage drug content and mainly cumulative percentage drug diffusion. The cumulative percentage drug diffused from F3 formulation was found to be 97.36 at the end of 24th hour.
Conclusion: Stable and effective transdermal drug delivery systems of metoprolol succinate for once daily administration were prepared for better patient compliance.

Keywords: Transdermal drug delivery, Solvent casting method, Metoprolol succinate, Ttherapeutic efficacy, Steady plasma level.

Doi : 10.18231/j.ijpca.2019.015

How to cite : Chakradhar D M, Sunitha A, Sofia B, Srikar G, Design and development of transdermal drug delivery systems of metoprolol succinate. Int J Pharm Chem Anal 2019;6(3):76-84

Copyright © 2019 by author(s) and Int J Pharm Chem Anal. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (